FDA Shakes Up Guidance on Antidepressant Trial Design - MedPage Today

Submitted by Anonymous (not verified) on Thu, 06/21/2018 - 20:01

MedPage TodayFDA Shakes Up Guidance on Antidepressant Trial DesignMedPage TodayThe FDA released new draft guidance for development and testing new pharmacologic agents indicated to treat major depressive disorder (MDD). For example, the new guidance offers specifics on testing the emerging classes of rapid-action antidepressants ...and more »